Issue 3/2016
Content (13 Articles)
In Memoriam: Pierre J. Meunier
Roland D. Chapurlat, Georges Boivin, Cyrus Cooper, Bess Dawson-Hughes, John A. Kanis, Jean-Yves Reginster, René Rizzoli
The Effect of Assisted Exercise Frequency on Bone Strength in Very Low Birth Weight Preterm Infants: A Randomized Control Trial
Ita Litmanovitz, Hedva Erez, Alon Eliakim, Sofia Bauer-Rusek, Shmuel Arnon, Rivka H. Regev, Gisela Sirota, Dan Nemet
Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion
Carlen Reyes, Anton Pottegård, Peter Schwarz, M. Kassim Javaid, Tjeerd P. Van Staa, Cyrus Cooper, Adolfo Diez-Perez, Bo Abrahamsen, Daniel Prieto-Alhambra
High Prevalence of Osteoporosis in Men with Distal Radius Fracture: A Cross-Sectional Study of 233 Men
Lisa Egund, Fiona McGuigan, Karin Önnby, Aleksander Giwercman, Kristina Akesson
Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)
Bente L. Langdahl, Östen Ljunggren, Claude-Laurent Benhamou, Fernando Marin, George Kapetanos, Tomaz Kocjan, Eric Lespessailles, Nicola Napoli, Tatjana Nikolic, Helmut Petto, Thomas Moll, Erik Lindh
Managing a Bone Healthy Lifestyle After Attending Multifaceted Group Education
Annesofie Lunde Jensen, Kirsten Lomborg, Bente Lomholt Langdahl, Gitte Wind
The Relationship of BMD Increases Between the First 12 Months and the Latter 12 Months by Daily Teriparatide Treatment
Rui Niimi, Toshibumi Kono, Atsushi Nishihara, Masahiro Hasegawa, Toshihiko Kono, Akihiro Sudo
Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat
Amy Creecy, Sasidhar Uppuganti, Alyssa R. Merkel, Dianne O’Neal, Alexander J. Makowski, Mathilde Granke, Paul Voziyan, Jeffry S. Nyman
Osterix and RUNX2 are Transcriptional Regulators of Sclerostin in Human Bone
Flor M. Pérez-Campo, Ana Santurtún, Carmen García-Ibarbia, María A. Pascual, Carmen Valero, Carlos Garcés, Carolina Sañudo, María T. Zarrabeitia, José A. Riancho
Does Activin Receptor Blockade by Bimagrumab (BYM338) Pose Detrimental Effects on Bone Healing in a Rat Fibula Osteotomy Model?
László B. Tankó, Jörg Goldhahn, Aurore Varela, Elisabeth Lesage, Susan Y. Smith, Andrew Pilling, Simon Chivers
Treatment of Paget’s Disease of Bone with Denosumab: Case Report and Literature Review
Ian R. Reid, Sonakshi Sharma, Ramanamma Kalluru, Carl Eagleton
Novel Compound Heterozygous Mutations in the CYP27B1 Gene Lead to Pseudovitamin D-Deficient Rickets
W. Nadia H. Koek, M. Carola Zillikens, Bram C. J. van der Eerden, Johannes P. T. M. van Leeuwen